
    
      A dose-titration approach will be used over three injection cycles, with a flexible
      observation period after injections of 12-16 weeks and a total duration of up to 48 weeks.
      Cycle 1 and 2: upper and/or lower limb to be treated; Cycle 3: upper and lower limb to be
      treated.
    
  